1/ Verily Life Sciences plans to restructure its strategy around artificial intelligence. The company aims to become a tech provider for healthcare through its AI models, apps, and infrastructure, marking a significant shift from its previous focus. Let's dive in 🧵👇

🤖 Software Dev by day and AI & Crypto
⭐ I love sharing all the new tech developments with you
📫 DM me for collaboration
🌐 AI MARKET WATCH --> t.co/WMNyhRhSAO

2/ Originally launched in 2015 as a moonshot project out of Google X, Verily is now deep into real-world precision medicine. Think: AI-driven diabetes care, digital clinical trials, and robotic surgery collabs.

4/ Verily’s “Lightpath” platform uses AI to personalize care plans, and their clinical research tools are digitizing trials to make them faster and cheaper. Their goal: take the chaos out of healthcare and make it feel… precision-engineered.

5/ And plot twist: Verily is slowly breaking off from Google’s core systems. Project Flywheel is helping them set up their own IT, HR, and data infra—like a grown-up startup under Alphabet. It’s a subtle flex toward long-term independence without dropping the Alphabet name (yet).

6/ Collab-wise, they’re stacked: GSK for bioelectronic medicine, J&J for robotic surgery, and Sanofi for chronic condition platforms. With $1B+ in funding and an AI-first mindset, Verily’s out here trying to make healthcare smarter, more personal, and way less painful.

https://verily.com/perspectives/verily-ai-precision-health-2025

https://communityimpact.com/dallas-fort-worth/lewisville-coppell/business/2024/07/25/alphabet-health-care-company-verily-life-sciences-moving-headquarters-to-cypress-waters/

https://www.businessinsider.com/verily-leave-google-alphabet-flywheel-life-sciences-2024-11

3/ In 2024, Verily made a big move—literally—shifting HQ from San Francisco to Dallas. Why? To get closer to booming healthcare and biotech hubs. Their strategy is all about combining AI + clinical data to treat stuff like diabetes, obesity, and other chronic conditions smarter.